Methyltransferase 1 is required for nonhomologous end‐joining repair and renders hepatocellular carcinoma resistant to radiotherapy
Hepatology · 2023-06 · 77 (6) · 1896-1910
DOI: 10.1002/hep.32615 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatology, online erschienen am 01.07.2022. Verfasst von Junbin Liao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery , Center of Hepato-Pancreato-Biliary Surgery , The First Affiliated Hospital , Sun Yat-sen University , Guangzhou , China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Background and Aims: Radiotherapy is an increasingly essential therapeutic strategy in the management of hepatocellular carcinoma (HCC). Nevertheless, resistance to radiotherapy is one of the primary obstacles to successful treatment outcomes. Hence, we aim to elucidate the mechanisms underlying radioresistance and identify reliable biotargets that would be inhibited to enhance the efficacy of radiotherapy in HCC. Approach and Results: From a label‐free quantitative proteome screening, we identified transfer RNA (tRNA; guanine‐ N [7]‐) methyltransferase 1 (METTL1), a key enzyme for N7‐methylguanosine (m 7 G) tRNA modification, as an essential driver for HCC cells radioresistance. We reveal that METTL1 promotes DNA double‐strand break (DSB) repair and renders HCC cells resistant to ionizing radiation (IR) using loss‐of‐function and gain‐of‐function assays in vitro and in vivo. Mechanistically, METTL1‐mediated m 7 G tRNA modification selectively regulates the translation of DNA‐dependent protein kinase catalytic subunit or DNA ligase IV with higher frequencies of m 7 G‐related codons after IR treatment, thereby resulting in the enhancement of nonhomologous end‐joining (NHEJ)–mediated DNA DSB repair efficiency. Clinically, high METTL1 expression in tumor tissue is significantly correlated with poor prognosis in radiotherapy‐treated patients with HCC. Conclusions: Our findings show that METTL1 is a critical enhancer for HCC cell NHEJ‐based DNA repair following IR therapy. These findings give insight into the role of tRNA modification in messenger RNA translation control in HCC radioresistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Liver Surgery , Center of Hepato-Pancreato-Biliary Surgery , The First Affiliated Hospital , Sun Yat-sen University , Guangzhou , China.
- Department of Radiation Oncology , The First Affiliated Hospital , Sun Yat-sen University , Guangzhou , China.
- Institute of Precision Medicine , The First Affiliated Hospital , Sun Yat-sen University , Guangzhou , China.
- Center for Translational Medicine , The First Affiliated Hospital , Sun Yat-sen University , Guangzhou , China.
- Clinical Trials Unit , The First Affiliated Hospital , Sun Yat-sen University , Guangzhou , China.
- Cancer Center , The First Affiliated Hospital , Sun Yat-sen University , Guangzhou , China.
Zitieren
APA
Liao, J., Yi, Y., Yue, X., Wu, X., Zhu, M., Chen, Y., Peng, S., Kuang, M., Lin, S., & Peng, Z. (2023). Methyltransferase 1 is required for nonhomologous end‐joining repair and renders hepatocellular carcinoma resistant to radiotherapy. Hepatology, 77(6), 1896-1910. https://doi.org/10.1002/hep.32615
Vancouver
Liao J, Yi Y, Yue X, Wu X, Zhu M, Chen Y, et al. Methyltransferase 1 is required for nonhomologous end‐joining repair and renders hepatocellular carcinoma resistant to radiotherapy. Hepatology. 2023;77(6):1896-1910. doi:10.1002/hep.32615
BibTeX
@article{Liao2023,
author = {Liao, Junbin and Yi, Yang and Yue, Xin and Wu, Xiaoxue and Zhu, Meiyan and Chen, Yong and Peng, Sui and Kuang, Ming and Lin, Shuibin and Peng, Zhenwei},
title = {Methyltransferase 1 is required for nonhomologous end‐joining repair and renders hepatocellular carcinoma resistant to radiotherapy},
journal = {Hepatology},
year = {2023},
volume = {77},
number = {6},
pages = {1896--1910},
doi = {10.1002/hep.32615}
}
EUVIMED